Stem cells are a relatively new concept in the medical and scientific community. It was introduced in the early 80s, but blew up in the late 90s.
What are stem cells though? Why are they important in these communities and why are they part of some interesting and passionate conversations that have clear divisions with people for and against it?
In a nutshell, stem cells are cells that have the capability to grow into many different types of cells. When introduced to the body, it will continue to divide and recreate itself into a number of different cells that the host may need.
They may turn into muscle tissues, blood cells, and even brain cells. Thus, the stem cell is a great tool to have and to use for any healing purposes.
The controversy comes due to the ethics of stem cells. Stem cells are found in a blastula which is essentially an egg from a female that is at an early development stage. Thus, people see it as a hindrance to human life.
For anyone who is new or on the fence, let’s take a look at some statistics about stem cells.
Past Stem Cell Statistics
More than 10 years ago, more than 60% of people in North America agreed with the usage of stem cell, as well as the research of it.
Almost 80% of all of this previous research on stem cells in America was being run by the federal government.
More than 50% of that research was regrettably being done on stem cell lines that were not up-to-date.
More than 60% of the research was being done on non-embryonic stem cell research.
Less than 20% was being done on embryonic stem cell research.
Despite the research being done for embryonic stem cells, the success rate is not as big as non-embryonic stem cells.
Back then, numerous states were pledging more than $4 million for research up to the year of 2018.
Almost $2 million alone would come from California.
President Bush promised at least 60 stem cell lines were to be researched.
However, only 21 of them were really eligible.
The State of Stem Cell Companies
If production and effectivity can be measured by money, signs are looking good. As much as $4 billion was raised by medical companies for all regenerative medicines in 2018.
For cell therapy, at least $2 billion was raised.
The previous year, less than half of this was raised.
Almost a billion dollars was raised by initial public offerings alone.
Nearly a thousand trials for therapies in the regenerative cell field took place last year throughout the whole world.
A little bit more than half of those therapies are for cancer.
Other therapies include cardiovascular diseases and musculoskeletal diseases.
As many as 60,000 people are taking part in these trials and therapies.
As of the 2nd half of last year, there are almost 900 companies that offer services in line with regenerative medicines. These include stem cells.
Majority of these companies is in North America.
Africa is a country that has only 1 of these companies.
Practical Stem Cell Statistics
In studies with blood diseases, the survival rate for patients using stem cells is an astounding 80 to 90%.
For diseases like Hodgkins, MDS, lymphomas, the survival rate is 45%.
Treatments using stem cells have already helped over a million people as of 2012.
By 2012, patients spanned more than 70 countries.
By 2018, there are no practical statistics on how many people have been treated with stem cells. But the number from 2012 is expected to have increased exponentially.
In 2014, 20,000 stem cell cases were in the United States.
More than 10 years ago, stem cells were already being used to treat over 70 conditions.
Conditions such as leukemia and myeloma have moved past trials. Stem cell treatment is now the standard treatment.
For myeloma, more than 20,000 transplants with bone marrow and umbilical cords were done early in 2010 up to 2014.
For the first few weeks, there is no improvement felt with stem cells.
By week 6 to 8, improvements are felt and keep increasing.
This is a hefty list of stem cell statistics. We can’t wait to see what else happens in the future of stem cells.